Advertisement

Topics

FOCUS Clinical Drug Development GmbH Company Profile

21:35 EDT 23rd September 2017 | BioPortfolio

FOCUS is an independent drug development organisation with 120 employees, offering full-service Phase I to III clinical development packages or individual service modules. The headquarters are located in Neuss/Duesseldorf, Germany with affiliates in Heidelberg, Moscow, Tokyo and Jakarta.

Location

Stresemannallee 6
Neuss
41460
Germany


News Articles [12314 Associated News Articles listed on BioPortfolio]

Roivant Sciences raises $1.1bn to support new subsidiaries

Roivant Sciences GMBH raised $1.1bn from lead investor SoftBank Vision Fund (the investment arm of Japanese tech giant SoftBank Group International) and additional returning backers including Dexxon. ...

ExB Labs And Alacris Theranostics GmbH Announce Strategic Collaboration In The Field Of Drug Development And Drug Response Prediction

  Life Sciences Jobs   ...

Endocyte Cuts Workforce by 40 Percent After Clinical Trial Falters

Endocyte is halting a clinical trial for one of its cancer drugs and narrowing the focus of another following a review of the two early-stage drug programs, the company announced Friday. The changes a...

Hepatera: Eligibility to PRIME Scheme Granted to Myrcludex B by the European Medicines Agency

MOSCOW, May 25, 2017 /PRNewswire/ -- MYR GmbH and its development partner Hepatera LLC today announced that the European Medicines Agency (EMA) granted "PRIME eligibility" for Myrcudex B, a first ...

New insight into BIA 10-2474 clinical trial shines light on preclinical testing

Experts are calling for an increased focus on human cellular model development after animal tests failed to detect the toxicity of an experimental drug before the first-in-human clinical trial that le...

Artificial Intelligence in Drug Development Congress - Final Agenda

Oxford Global is pleased to share with you the final agenda for our highly anticipated Artificial Intelligence in Drug Development Congress taking place 27 – 28 September 2017 in London.Join us acro...

Debiopharm Enters The Field Of Antibody-Drug Conjugates Through Acquisition Of Phase II Asset From ImmunoGen

Transaction adds innovative clinical-stage program to expanding Debiopharm portfolio and broadens its clinical development expertise Divestiture aligns with ImmunoGens focus o...

FDA's Gottlieb Pushing 'Seamless' Clinical Trials For Faster Development

US FDA Commissioner notes that combined-phase clinical trials could be expanded beyond oncology as one way of reducing drug development...  &

PubMed Articles [11946 Associated PubMed Articles listed on BioPortfolio]

Age and Sex in Drug Development and Testing for Adults.

Individualization of drug therapy requires that the right drug be administered at the correct dose to patients who are likely to achieve the highest benefit and lowest risk. Female sex and age compris...

Discovery and Development of Novel Drugs.

Drug discovery and development process is nowadays conducted in relatively standardised sequence of phases, starting with Discovery and being followed by Preclinical, Clinical and Non-Clinical Develop...

Fit for purpose and modern validity theory in clinical outcomes assessment.

The US Food and Drug Administration (FDA), as part of its regulatory mission, is charged with determining whether a clinical outcome assessment (COA) is "fit for purpose" when used in clinical trials ...

Drug discovery and development for rare genetic disorders.

Approximately 7,000 rare diseases affect millions of individuals in the United States. Although rare diseases taken together have an enormous impact, there is a significant gap between basic research ...

Novel strategies to prevent the development of multidrug resistance (MDR) in cancer.

The development of multidrug resistance (MDR) is one of the major challenges to the success of traditional chemotherapy treatment in cancer patients. Most studies to date have focused on strategies to...

Clinical Trials [5782 Associated Clinical Trials listed on BioPortfolio]

Development of a Clinical Trial Specific Question Prompt List

The purpose of this study is to develop a Question Prompt List (QPL) about clinical trials for cancer patients and find out what cancer patients and their caregivers think of the QPL. A QP...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Computational Drug Repurposing for EBS

The study will compare gene expression differences between blistered and non-blistered skin from individuals with EBS, as well as normal skin from non-EBS subjects. State of the art comput...

Development of a Life Skills Intervention for Young Adolescents Perinatally-Infected With HIV and Their Caregivers

During this phase of the study, a focus group will be conducted with young adolescents perinatally infected with HIV and with their caregivers to develop and evaluate the content of the pr...

FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

Drug-resistant tuberculosis is becoming a major problem for the whole humanity, and development of new Anti-TB drugs is of great importance. Since Kazakhstan is a country with the high bur...

Companies [5934 Associated Companies listed on BioPortfolio]

FGK Clinical Research GmbH

As contract research organization FGK GmbH provides a wide range of services in drug and medical device development from early conception until final report. FGK has a focus on biotech companies which...

FOCUS Clinical Drug Development GmbH

FOCUS is an independent drug development organisation with 120 employees, offering full-service Phase I to III clinical development packages or individual service modules. The headquarters are located...

FAN GmbH

FAN GmbH - a centre of excellence for drug discovery with focus on diseases of the central nervous system Preclinical contract research - stroke and ischemia, Alzheimers disease,neuroprotection, neuro...

Avontec GmbH

AVONTEC GmbH is a phase II biopharmaceutical company engaged in the development of a novel class of anti-inflammatory drugs that are based on double-stranded DNA oligonucleotides acting as decoys (dec...

INNOPHAR GmbH

"The InnoPhaR GmbH is a clinical research organization with focus on the conduct of clinical studies in Eastern Europe. Besides first administration in man with young, healthy volunteers the main emph...

More Information about "FOCUS Clinical Drug Development GmbH" on BioPortfolio

We have published hundreds of FOCUS Clinical Drug Development GmbH news stories on BioPortfolio along with dozens of FOCUS Clinical Drug Development GmbH Clinical Trials and PubMed Articles about FOCUS Clinical Drug Development GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of FOCUS Clinical Drug Development GmbH Companies in our database. You can also find out about relevant FOCUS Clinical Drug Development GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record